Hemophiliaworld.org

Hemophiliaworld.org has Server used 184.168.131.241 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first Unknown and hosted in Scottsdale United States, server ping response time 67 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Hemophiliaworld keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Hemophilia world
2 Hemophilia worldwide
3 Hemophilia world history
4 Hemophilia worldwide revenues
5 Hemophilia world federation
6 Hemophilia world statistics
7 Hemophilia worldwide stats
8 Hemophilia worldwide incidence
9 Hemophilia word root

Hosting Provider

Website: Hemophiliaworld.org
Hostname: ip-184-168-131-241.ip.secureserver.net
Country:
Region: AZ
City: Scottsdale
Postal Code: 85260
Latitude: 33.61190032959
Longitude: -111.89060211182
Area Code: 480
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   Whitecoschools.net (1 seconds ago)

   Pysanka.com (6 seconds ago)

   Voamid.org (12 seconds ago)

   Miet.pro (4 seconds ago)

   Macrealestate.com (1 seconds ago)

   Ciaonlinebuyntx.com (7 seconds ago)

   Ogura-yui.com (1 min ago)

   Inzai.net (18 seconds ago)

   Buyacademy.net (23 seconds ago)

   Turismoytren.com (40 seconds ago)

   Medicalhair4u.com (3 seconds ago)

   Lincolnherald.net (6 seconds ago)

   Vermillionmenus.com (1 seconds ago)

   Hemophiliaworld.org (0 seconds ago)

   Cotobaco.com (1 min ago)

   Dignitytravel.biz (6 seconds ago)

   Crorkservice.com (11 seconds ago)

   100zp.com (4 seconds ago)

   Takaki-circ.com (8 seconds ago)

   Tellhancock.com (12 seconds ago)

Results For Websites Listing

Found 82 Websites with content related to this domain, It is result after search with search engine

Home - World Federation of Hemophilia

Featured Resource. Learn all about gene therapy for hemophilia in this fun interactive module. Explaining everything from the basics of gene expression and transfer to the ongoing investigations into safety, efficacy, and predictability in clinical trials, this resource provides foundational knowledge for people with hemophilia and healthcare professionals alike.

https://www.wfh.org/en/page.aspx?pid=492

Hemophilia World News - The latest news about the WFH and

Maaz Ullah is a 25 year old man with hemophilia B from Upper Dir, Pakistan. Diagnosed with retroperitonial hematoma, Maaz Ullah underwent surgery in Peshawar, and was given donated factor provided by

https://news.wfh.org/

Haemophilia - Wikipedia

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding for a longer time after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with a mild case of the disease may have symptoms only after an accident or during surgery.

https://en.m.wikipedia.org/wiki/Haemophilia

Hemophilia A | National Hemophilia Foundation

Hemophilia A, also called factor VIII (FVIII) deficiency or classic hemophilia, is a genetic disorder caused by missing or defective factor VIII, a clotting protein. Although it is passed down from parents to children, about 1/3 of cases are caused by a spontaneous mutation, a change in a gene.

https://www.hemophilia.org/Bleeding-Disorders/Types-of-Bleeding-Disorders/Hemophilia-A

HEMOPHILIA - HealthNet

It was estimated in 1990 that there were 350, 000 individuals with hemophilia world wide with 80% or 280, 000 without treatment. The disease is incurable, but if the baby is early diagnosed and treated early with adequate replacement of the deficient coagulation factor,

https://healthnet.org.np/article/misc/hemophilia.html

GUIDELINES FOR THE MANAGEMENT OF HEMOPHILIA

GUIDELINES FOR THE MANAGEMENT OF HEMOPHILIA 2nd edition Prepared by the Treatment Guidelines Working Group, on behalf of the World Federation of Hemophilia (WFH) Dr. Alok Srivastava (Chair) Department of Hematology, Christian Medical College, Vellore, Tamil Nadu, India Dr. Andrew K. Brewer Department of Oral Surgery, The Royal Infirmary,

https://www1.wfh.org/publication/files/pdf-1472.pdf

WFH eLearning Platform - Guidelines for the Management of

Hemophilia is a rare disorder that is complex to diagnose and manage. By compiling the second edition of its Guidelines for the Management of Hemophilia, the World Federation of Hemophilia (WFH) aims to provide practical, evidence-based guidance to healthcare providers, government authorities, and patient organizations seeking to initiate and/or maintain hemophilia care programs.

https://elearning.wfh.org/resource/treatment-guidelines/

World Federation of Hemophilia

English: www.wfh.org/en Español: www.wfh.org/es Français: www.wfh.org/fr

https://www.wfh.org/

WFH eLearning Platform - Gene Therapy for Hemophilia

Adapted from: Global NMO Training 2018 plenary presentation by Glenn Pierce Reviewed by: Glenn Pierce Edited by: Georghia Michael. The learner is strongly advised to complete Module 1 Introduction to Bleeding Disorders and Module 2 Evolution of Treatment Products, in the WFH Treatment Products eLearning Program before embarking upon Module 3.. This third module in the Program explains the

https://elearning.wfh.org/resource/gene-therapy-for-hemophilia/

A WFH Advisory on Particulate Matter in Emicizumab

Since the development of intravenous therapies, the presence of particulate matter in injectable drugs has been a concern for clinicians. While some particles can come from outside sources (e.g. when the product is prepared for use), others are “intrinsic” to the manufacturing process specific to the drug. In the latter case, sources for these particles

https://news.wfh.org/a-wfh-advisory-on-particulate-matter-in-emicizumab-hemlibra-and-other-biologic-agents/

Recently Analyzed Sites